Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer.

By Misop Han, Alan W. Partin, M. Zahurak, S. Piantadosi, J. I. Epstein, P. Walsh. Journal of Urology, 2003

829 citations recorded by the source corpus.

Subfields: Molecular Biology, Pulmonary and Respiratory Medicine

View Paper: https://www.semanticscholar.org/paper/ec9c59e7a9e930631ea01876b397af1c208dadc9

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. E. Even-Sapir
2. E. Mishani
3. I. Leibovitch
4. H. Lerman
5. U. Metser
6. Gennady Lievshitz

Citations in the corpus

• The detection of bone metastases in patients with high-risk prostate cancer: 99mTc-MDP Planar bone scintigraphy, single- and multi-field-of-view SPECT, 18F-fluoride PET, and 18F-fluoride PET/CT. (2006, background): “The most frequent sites of metastasis are lymph nodes and bone; 90% of patients who die of prostate cancer harbor bone metastases (2,9).”